These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1726333)

  • 1. Granulocytic colony-stimulating factors (G-CSF and GM-CSF) in the treatment of adult acute myeloid leukemia.
    Dombret H; Toubert ME; Schlageter MH; Chomienne C; Degos L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):445-8. PubMed ID: 1726333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors.
    Hiddemann W; Wörmann B; Reuter C; Schleyer E; Zühlsdorf M; Böckmann A; Büchner T
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction.
    Lanza F; Rigolin GM; Castagnari B; Moretti S; Castoldi G
    Haematologica; 1997; 82(2):239-45. PubMed ID: 9175331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML).
    Wörmann B; Hiddemann W; Frisch J; Zühlsdorf M; Rottmann R; Boeckmann A; Reuter C; Freire EA; Innig G; Schulz G
    Behring Inst Mitt; 1991 Dec; (90):28-38. PubMed ID: 1801688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
    Ottmann OG; Bug G; Krauter J
    Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental basis for the use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with acute myeloid leukemia.
    Wörmann B; Reuter C; Zühlsdorf M; Büchner T; Hiddemann W
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):39-43. PubMed ID: 7801145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic growth factors in acute myeloid leukemia: supportive and priming effects.
    Büchner T; Hiddemann W; Wörmann B; Zühlsdorf M; Rottmann R; Innig G; Maschmeier G; Ludwig WD; Sauerland MC; Heinecke A
    Semin Oncol; 1997 Feb; 24(1):124-31. PubMed ID: 9045298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor in acute myeloid leukemia.
    Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
    Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
    Chen J; Zhou JH; Ball ED
    Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic growth factors in the reduction of chemotherapeutic toxicity.
    Johnston EM; Crawford J
    Semin Oncol; 1998 Oct; 25(5):552-61. PubMed ID: 9783594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY; Xu B; Sun J; Yang Y; Niu JN
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) treatment of patients with acute leukemias in aplasia and at high risk of early death.
    Büchner T; Hiddemann W; Zühlsdorf M; Koenigsmann M; Böckmann A; van de Loo J; Schulz G
    Behring Inst Mitt; 1988 Aug; (83):309-12. PubMed ID: 3071345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications.
    Ringdén OT; Le Blanc K; Remberger M
    Exp Hematol; 2005 May; 33(5):505-12. PubMed ID: 15850828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.
    Geller RB
    J Clin Oncol; 1996 Apr; 14(4):1371-82. PubMed ID: 8648396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.